• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchAtrium Therapeutics
    Picture of Atrium Therapeutics logo

    RNA — Atrium Therapeutics Share News

    $8.200.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeSmall CapNeutral
    • Market Cap
      $140.27m
    • Enterprise Value
      -$123.63m
    • Revenue
      $18.62m
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • RNA Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    RNA Dividends
    • Brief: Atrium Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

      20/10/2026 23:04
    • Brief: Yakira Capital Management Calls On Atrium Therapeutics To Launch Strategic Review

      20/10/2026 13:33
    • US STOCKS ON THE MOVE-Palantir, Haemonetics

      08/10/2026 19:15
    • U.S. STOCKS ON THE MOVE-Palantir, Haemonetics, Starbucks

      08/10/2026 17:20
    • Atrium Therapeutics rallies after $50 mln equity raise

      08/10/2026 12:55
    • Brief: Atrium Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule

      20/08/2026 23:26
    • Heart drug developer Atrium Therapeutics' Q2 loss widens as expenses rise

      13/08/2026 22:46
    • Atrium Therapeutics Q1 collaboration revenue surges after spin-off

      14/05/2026 21:50
    • U.S. STOCKS ON THE MOVE- Lululemon, United Rentals, cannabis stocks

      23/04/2026 18:44
    • U.S. STOCKS ON THE MOVE- American Airlines, Pot stocks, Paramount Skydance

      23/04/2026 16:39
    • Atrium Therapeutics rises on $15 million milestone payment from Bristol Myers Squibb

      23/04/2026 15:13

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.